The Japanese Breast Cancer Society clinical practice guideline for surgical treatment of breast cancer, 2015 edition

Hiromitsu Jinno; Masafumi Inokuchi; Toshikazu Ito; Kaoru Kitamura; Goro Kutomi; Takehiko Sakai; Yuko Kijima; Noriaki Wada; Yoshinori Ito; Hirofumi Mukai

doi:10.1007/s12282-016-0671-x

The Japanese Breast Cancer Society clinical practice guideline for surgical treatment of breast cancer, 2015 edition

Hiromitsu Jinno, Masafumi Inokuchi, Toshikazu Ito, Kaoru Kitamura, Goro Kutomi, Takehiko Sakai, Yuko Kijima, Noriaki Wada, Yoshinori Ito, Hirofumi Mukai

研究成果: Article › 査読

14 被引用数 (Scopus)

本文言語	English
ページ（範囲）	367-377
ページ数	11
ジャーナル	Breast Cancer
巻	23
号	3
DOI	https://doi.org/10.1007/s12282-016-0671-x
出版ステータス	Published - 01-05-2016
外部発表	はい

All Science Journal Classification (ASJC) codes

腫瘍学
放射線学、核医学およびイメージング
薬理学（医学）

文献へのアクセス

10.1007/s12282-016-0671-x

他のファイルとリンク

引用スタイル

@article{9f56c47444c641289fb2d05d02a1bac0,

title = "The Japanese Breast Cancer Society clinical practice guideline for surgical treatment of breast cancer, 2015 edition",

author = "Hiromitsu Jinno and Masafumi Inokuchi and Toshikazu Ito and Kaoru Kitamura and Goro Kutomi and Takehiko Sakai and Yuko Kijima and Noriaki Wada and Yoshinori Ito and Hirofumi Mukai",

note = "Funding Information: Yoshinori Ito received lecture fees from Chugai, Esai, and Novartis and research grants from Novartis, Chugai, Parexel, Esai, Sanofi, Taiho, EPS, Dai-ichi-sankyo, and Boehringer-ingelheim. The other authors declared no potential conflicts of interest.",

year = "2016",

month = may,

day = "1",

doi = "10.1007/s12282-016-0671-x",

language = "English",

volume = "23",

pages = "367--377",

journal = "Breast Cancer",

issn = "1340-6868",

publisher = "Springer Japan",

number = "3",

}

TY - JOUR

T1 - The Japanese Breast Cancer Society clinical practice guideline for surgical treatment of breast cancer, 2015 edition

AU - Jinno, Hiromitsu

AU - Inokuchi, Masafumi

AU - Ito, Toshikazu

AU - Kitamura, Kaoru

AU - Kutomi, Goro

AU - Sakai, Takehiko

AU - Kijima, Yuko

AU - Wada, Noriaki

AU - Ito, Yoshinori

AU - Mukai, Hirofumi

N1 - Funding Information: Yoshinori Ito received lecture fees from Chugai, Esai, and Novartis and research grants from Novartis, Chugai, Parexel, Esai, Sanofi, Taiho, EPS, Dai-ichi-sankyo, and Boehringer-ingelheim. The other authors declared no potential conflicts of interest.

PY - 2016/5/1

Y1 - 2016/5/1

UR - http://www.scopus.com/inward/record.url?scp=84964307505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964307505&partnerID=8YFLogxK

U2 - 10.1007/s12282-016-0671-x

DO - 10.1007/s12282-016-0671-x

M3 - Article

C2 - 26921084

AN - SCOPUS:84964307505

VL - 23

SP - 367

EP - 377

JO - Breast Cancer

JF - Breast Cancer

SN - 1340-6868

IS - 3

ER -